Is Virpax Pharmaceuticals, Inc. (VRPX) a Buy, Sell, or Hold?
OTC : VRPX
Virpax Pharmaceuticals, Inc. — Institutional Ownership
$0.0001 USD
$0 (0.0%)
- Volume
- 51
- Average Volume
- 410
- Market Capitalization
- $124
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- $3.00
- Year High
- $0.10
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.63
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2024-05-23 | Intracoastal Capital LLC | 110.73K | 4.99% |
| 2024-05-23 | Mitchell P. Kopin | 110.73K | 4.99% |
| 2024-05-23 | Daniel B. Asher | 110.73K | 4.99% |
| 2022-02-14 | CVI Investments, Inc. | - | 0.00% |
| 2022-02-14 | Virpax Pharmaceuticals, LLC | 2.73M | 23.30% |
| 2022-02-14 | Anthony P. Mack | 2.97M | 25.20% |
| 2022-02-14 | Heights Capital Management, Inc. | - | 0.00% |
| 2022-02-04 | Mark Carhart | 750K | 6.40% |
| 2022-02-04 | Kepos Capital LP | 750K | 6.40% |
| 2021-09-23 | NAME OF REPORTING PERSONS | 928.25M | 9.00% |
| 2021-09-23 | NAME OF REPORTING PERSONS | 928.25M | 9.00% |
| 2021-09-23 | NAME OF REPORTING PERSONS | 928.25M | 9.00% |
| 2021-09-21 | Altium Capital Management, LP | 1M | 8.50% |
| 2021-09-21 | Altium Growth Fund, LP | 1M | 8.50% |
| 2021-09-21 | Altium Growth GP, LLC | 1M | 8.50% |
| 2021-09-20 | Heights Capital Management, Inc. | 1M | 8.50% |
| 2021-09-20 | CVI Investments, Inc. | 1M | 8.50% |
VRPX Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2024-12-31 | $9.50 | 4.25M | $40.42M | $1.51M | -$ | $38.9M |
| 2023-12-31 | $80.00 | 1.17M | $93.7M | $9.14M | -$ | $84.56M |
| 2022-12-31 | $155.50 | 1.17M | $182.12M | $19M | -$ | $163.13M |
| 2021-12-31 | $857.50 | 1.17M | $1B | $36.84M | -$ | $967.71M |
| 2020-12-31 | $1632.50 | 494.52K | $807.3M | $54796 | $1.57M | $808.81M |
| 2019-12-31 | $1632.50 | 521.52K | $851.37M | $41536 | $1.26M | $852.6M |
| 2018-12-31 | $1632.50 | 4.95M | $8.07B | $48370 | $500K | $8.07B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2024-12-31 | $9.50 | 4.25M | $40.42M | $1.51M | -$ | $38.9M |
| 2024-09-30 | $17.36 | 4.66M | $80.86M | $17229 | -$ | $80.84M |
| 2024-06-30 | $12.53 | 1.98M | $24.77M | $1.87M | -$ | $22.9M |
| 2024-03-31 | $105.25 | 1.17M | $123.27M | $1.87M | -$ | $121.41M |
| 2023-12-31 | $80.00 | 1.17M | $93.7M | $9.14M | -$ | $84.56M |
| 2023-09-30 | $200.00 | 1.17M | $234.29M | $12.15M | -$ | $222.13M |
| 2023-06-30 | $270.00 | 1.17M | $316.29M | $14.8M | -$ | $301.48M |
| 2023-03-31 | $196.25 | 1.17M | $229.89M | $16.99M | -$ | $212.91M |
| 2022-12-31 | $155.50 | 1.17M | $182.16M | $19M | -$ | $163.16M |
| 2022-09-30 | $297.50 | 11.71M | $3.48B | $20.56M | -$ | $3.46B |
| 2022-06-30 | $420.00 | 11.71M | $4.92B | $26.06M | -$ | $4.89B |
| 2022-03-31 | $555.00 | 11.71M | $6.5B | $30.8M | -$ | $6.47B |